Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Millard

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Health Services : Planning, Administration, Evaluation|January 1, 1982
Health care in Poland: from crisis to crisisL F Millard
Actas Dermo-Sifiliograficas|July 8, 2017
Color Doppler Ultrasound Study of Glomuvenous Malformations with its Clinical and Histologic CorrelationsX Wortsman, F Millard, L Aranibar
Cancer|May 20, 1998
Oncology services: the Department of Defense perspectiveD Browne, L M Baatz, F Millard, et al.
American Journal of Hematology|April 3, 2001
Neutropenic enterocolitis: a rare presenting complication of acute leukemiaM M Quigley, K Bethel, M Nowacki, et al.
Blood|October 1, 1987
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITPR McMillan, P Tani, F Millard, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BH L Kindler, F Millard, J E Herndon, et al.
Journal of Molecular Biology|June 11, 2025
The Ensemble Basis of Allostery and Function: Insights from Models of Local UnfoldingCharles E F Millard, James O Wrabl, Sarah J Brantley, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2019
The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid ReceptorBenjamin Small, Charles E F Millard, Edwina P Kisanga, et al.
Annual Review of Biophysics|February 10, 2025
Statistical Thermodynamics of the Protein Ensemble: Mediating Function and EvolutionVincent J Hilser, James O Wrabl, Charles E F Millard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207J E Rosenberg, S Halabi, B L Sanford, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Health Services : Planning, Administration, Evaluation|January 1, 1982
Health care in Poland: from crisis to crisisL F Millard
Actas Dermo-Sifiliograficas|July 8, 2017
Color Doppler Ultrasound Study of Glomuvenous Malformations with its Clinical and Histologic CorrelationsX Wortsman, F Millard, L Aranibar
Cancer|May 20, 1998
Oncology services: the Department of Defense perspectiveD Browne, L M Baatz, F Millard, et al.
American Journal of Hematology|April 3, 2001
Neutropenic enterocolitis: a rare presenting complication of acute leukemiaM M Quigley, K Bethel, M Nowacki, et al.
Blood|October 1, 1987
Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITPR McMillan, P Tani, F Millard, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BH L Kindler, F Millard, J E Herndon, et al.
Journal of Molecular Biology|June 11, 2025
The Ensemble Basis of Allostery and Function: Insights from Models of Local UnfoldingCharles E F Millard, James O Wrabl, Sarah J Brantley, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2019
The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid ReceptorBenjamin Small, Charles E F Millard, Edwina P Kisanga, et al.
Annual Review of Biophysics|February 10, 2025
Statistical Thermodynamics of the Protein Ensemble: Mediating Function and EvolutionVincent J Hilser, James O Wrabl, Charles E F Millard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207J E Rosenberg, S Halabi, B L Sanford, et al.
Pageof 2